127 related articles for article (PubMed ID: 16421173)
1. The CAREGENE study: polymorphisms of the beta1-adrenoceptor gene and aerobic power in coronary artery disease.
Defoor J; Martens K; Zielinska D; Matthijs G; Van Nerum H; Schepers D; Fagard R; Vanhees L
Eur Heart J; 2006 Apr; 27(7):808-16. PubMed ID: 16421173
[TBL] [Abstract][Full Text] [Related]
2. Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers.
Schwartz SG; Puckett BJ; Allen RC; Castillo IG; Leffler CT
Ophthalmology; 2005 Dec; 112(12):2131-6. PubMed ID: 16325708
[TBL] [Abstract][Full Text] [Related]
3. beta1-Adrenoceptor gene polymorphism predicts long-term changes in body weight.
Linné Y; Dahlman I; Hoffstedt J
Int J Obes (Lond); 2005 May; 29(5):458-62. PubMed ID: 15685248
[TBL] [Abstract][Full Text] [Related]
4. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.
Liu J; Liu ZQ; Tan ZR; Chen XP; Wang LS; Zhou G; Zhou HH
Clin Pharmacol Ther; 2003 Oct; 74(4):372-9. PubMed ID: 14534524
[TBL] [Abstract][Full Text] [Related]
5. Cardiac reserve in the transplanted heart: effect of a graft polymorphism in the beta1-adrenoceptor.
Scharin Täng M; Lindberg E; Grüner Sveälv B; Magnusson Y; Andersson B
J Heart Lung Transplant; 2007 Sep; 26(9):915-20. PubMed ID: 17845930
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of beta1 adrenergic receptor and their influence on the cardiovascular responses to metoprolol in a South Indian population.
Mahesh Kumar KN; Ramu P; Rajan S; Shewade DG; Balachander J; Adithan C
J Cardiovasc Pharmacol; 2008 Nov; 52(5):459-66. PubMed ID: 19033826
[TBL] [Abstract][Full Text] [Related]
7. Beta1-adrenergic receptor polymorphisms, QTc interval and occurrence of symptoms in type 1 of long QT syndrome.
Paavonen KJ; Swan H; Piippo K; Laitinen P; Fodstad H; Sarna S; Toivonen L; Kontula K; Viitasalo M
Int J Cardiol; 2007 May; 118(2):197-202. PubMed ID: 17023080
[TBL] [Abstract][Full Text] [Related]
8. Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases.
Brodde OE
Fundam Clin Pharmacol; 2008 Apr; 22(2):107-25. PubMed ID: 18353108
[TBL] [Abstract][Full Text] [Related]
9. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.
Forleo C; Sorrentino S; Guida P; Romito R; De Tommasi E; Iacoviello M; Pitzalis M
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):589-95. PubMed ID: 17667029
[TBL] [Abstract][Full Text] [Related]
10. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
[TBL] [Abstract][Full Text] [Related]
11. The CAREGENE study: genetic variants of the endothelium and aerobic power in patients with coronary artery disease.
Onkelinx S; Cornelissen V; Defoor J; Matthijs G; Thomaes T; Coeckelberghs E; Buys R; Schepers D; Fagard R; Vanhees L
Acta Cardiol; 2011 Aug; 66(4):407-14. PubMed ID: 21894794
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants of beta(1)-adrenoceptor gene polymorphisms (Ser49Gly and Arg389Gly) and essential hypertension in a south Indian Tamil population.
Ramu P; Rajan S; Shewade DG; Swaminathan RP; Dutta TK; Balachander J; Adithan C
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):576-82. PubMed ID: 19673943
[TBL] [Abstract][Full Text] [Related]
13. Beta1 and beta2-adrenergic receptor polymorphisms and idiopathic ventricular arrhythmias.
Ulucan C; Cetintas V; Tetik A; Eroglu Z; Kayikcioglu M; Can LH; Payzin S; Aydin M; Hasdemir C
J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1053-8. PubMed ID: 18479335
[TBL] [Abstract][Full Text] [Related]
14. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
[TBL] [Abstract][Full Text] [Related]
15. The CAREGENE study: ACE gene I/D polymorphism and effect of physical training on aerobic power in coronary artery disease.
Defoor J; Vanhees L; Martens K; Matthijs G; Van Vlerken A; Zielinska D; Schepers D; Vlietinck R; Fagard R
Heart; 2006 Apr; 92(4):527-8. PubMed ID: 16085717
[No Abstract] [Full Text] [Related]
16. Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy.
Paczkowska A; Szperl M; Małek Ł; Mazurkiewicz Ł; Skóra E; Grzybowski J; Roszczynko M; Bilińska Z; Tesson F; Ruzyłło W
Kardiol Pol; 2009 Mar; 67(3):235-41. PubMed ID: 19378229
[TBL] [Abstract][Full Text] [Related]
17. Influence of phenotype and pharmacokinetics on beta-blocker drug target pharmacogenetics.
Beitelshees AL; Zineh I; Yarandi HN; Pauly DF; Johnson JA
Pharmacogenomics J; 2006; 6(3):174-8. PubMed ID: 16402084
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure.
Wagoner LE; Craft LL; Zengel P; McGuire N; Rathz DA; Dorn GW; Liggett SB
Am Heart J; 2002 Nov; 144(5):840-6. PubMed ID: 12422153
[TBL] [Abstract][Full Text] [Related]
19. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
Liu J; Liu ZQ; Yu BN; Xu FH; Mo W; Zhou G; Liu YZ; Li Q; Zhou HH
Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
[TBL] [Abstract][Full Text] [Related]
20. Distributive characteristics of Ser49Gly and Gly389Arg genetic polymorphisms of beta1-adrenoceptor in Chinese Han and Dai populations.
Liu ZQ; Liu J; Xiang ZH; Hu MY; Mo W; Wang LS; Ou-Yang DS; He N; Wang D; Zhou HH
Acta Pharmacol Sin; 2006 Feb; 27(2):254-8. PubMed ID: 16412278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
